SOURCE: Applied DNA Sciences

Applied DNA Sciences

February 17, 2015 05:30 ET

Applied DNA Sciences Launches DNA Mark Identification Technology Platform -- DNA Beacon™

Encrypted Fluorescence Is Covert, Mobile and Adaptable Across Many Industries

STONY BROOK, NY--(Marketwired - February 17, 2015) - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, is launching a new technology, based on the use of a panel of novel, fluorescent, encrypted security elements, the patent-pending "DNA Beacon" technology, that is designed to integrate seamlessly with our SigNature® DNA platform. 

The Beacon technology is designed to identify APDN DNA-marked products, by encrypted fluorescence, throughout an entire supply chain or through high-value asset chain-of-custody. By combining our flagship SigNature DNA mark with the new Beacon technology, APDN's new combined technology platform can now accelerate the fight against counterfeiting, diversion and theft. Once a product is marked, identification in the field is easily conducted with the use of a simple Beacon activator (which chemically decrypts the Beacon) and a UV light, to be followed by forensic-grade DNA authentication, when required.

An indication of the unique robustness of the Beacon technology is its ability to survive flame temperatures in excess of 1000°C. Thus, it is well suited to prevent crimes such as copper theft where criminals sometimes burn the wire sheathing to expose bare copper for sale.

Many industries can take advantage of this new integrated [SigNature DNA + Beacon] technology platform: to protect consumer packaged goods, luxury brands, government commodities, copper, plastics, the printing and packaging of documents and labels for field inspection, and the protection of cash and valuables in the home or in transit. With this new technology pair, companies can realize higher confidence in field-level screening to combat counterfeiting, diversion and theft by integrating Beacon and SigNature DNA together as a combination taggant into their product lines.

The technology has already been endorsed and incorporated in labeling solutions provided by CCL Label, a world leader in security labeling and packaging. Additional feasibility trials have taken place with customers in the electronics, athletic wear, pharmaceuticals, plastics and book-publishing businesses.

This new technology platform complements APDN's current product, solution and service portfolio, including the recently announced Multi-Modal reader prototype. These interlocking platforms offer the marketplace an array of DNA-based security solutions, which enable users to DNA-mark, identify and authenticate a product or asset as it moves through a secure supply chain or between people or facilities.

"Beacon is another breakthrough technology allowing us to address the demands of our customers to conduct covert in-field inspections, protecting their products and assets," said Dr. James Hayward, President and CEO, Applied DNA Sciences.

About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Applied DNA Sciences' common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW. 

Forward-Looking Statement
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, and our subsequent quarterly report on Form 10-Q, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information